GT
AXLA

Glenmede Trust’s Axcella Health Inc. Common Stock AXLA Stock Holding History

Glenmede Trust’s Portfolio AXLA Stock Details AXLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-7
Closed – – 2398
2020
Q3 		$0 Hold
7
– – ﹤0.01% 2619
2020
Q2 		$0 Buy
+7
New +$856 ﹤0.01% 2667

Other funds holding AXLA

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HP
Harbourvest Partners Boston, Massachusetts $101M AUM 38.13% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Glenmede Trust's AXLA Position: Q4 2020 in Review

Glenmede Trust sold out of Axcella Health Inc. Common Stock (AXLA) in Q4 2020, closing a stake of 7 shares.

Glenmede Trust first reported a position in AXLA in Q2 2020 and held it in 2 quarters. The position peaked at $0 in Q3 2020. 47 funds tracked by Wall St. Rank hold AXLA as of Q4 2020.

  • Glenmede Trust reported no remaining Axcella Health Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • Glenmede Trust sold 7 Axcella Health Inc. Common Stock shares in Q4 2020.
  • Glenmede Trust first reported a position in Axcella Health Inc. Common Stock in Q2 2020 and held it in 2 quarters.
  • Glenmede Trust's Axcella Health Inc. Common Stock position peaked at $0 in Q3 2020.
  • 47 funds tracked by Wall St. Rank held Axcella Health Inc. Common Stock as of Q4 2020.

Based on Glenmede Trust's 13F filing for Q4 2020, filed 16 Feb 2021.